Literature DB >> 10960661

Lymphocyte-endothelial cell adhesive interactions in lung immunity: lessons from the murine response to particulate antigen.

J L Curtis1, F M Wolber, J Sonstein, R A Craig, T Polak, R N Knibbs, J Todt, G D Seitzman, L M Stoolman.   

Abstract

The adhesive interaction between lymphocytes and lung endothelial cells presents an attractive arena for the development of novel therapeutic agents to modify pathologic pulmonary immune responses. The conceptual basis for choosing molecular targets to modulate this adhesive interaction derives, in large part, from results of murine experimental model systems of the pulmonary immune response. This article reviews one such model, the response of primed C57BL/6 mice to the particulate antigen sheep erythrocytes. Novel data are presented on the effect of a blocking anti-alpha(4) integrin monoclonal antibody on lung leukocyte and lymphocyte subset accumulation after intratracheal (IT) antigen challenge. Results from this model system have indicated that lymphocytes may use either the endothelial selectins or alpha(4) integrin as independent pathways to initiate recruitment into the lungs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960661     DOI: 10.1016/s0162-3109(00)00221-6

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  4 in total

1.  Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.

Authors:  Jeffrey L Curtis; Joanne Sonstein; Ronald A Craig; Jill C Todt; Randall N Knibbs; Timothy Polak; Daniel C Bullard; Lloyd M Stoolman
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

2.  Primary human alveolar epithelial cells can elicit the transendothelial migration of CD14+ monocytes and CD3+ lymphocytes.

Authors:  M Eghtesad; H E Jackson; A C Cunningham
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

3.  Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury.

Authors:  Aisha Zaman; Zheng Cui; Joseph P Foley; Hengjiang Zhao; Paul C Grimm; Horace M Delisser; Rashmin C Savani
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-21       Impact factor: 6.914

4.  Kre-Celazine(®) as a viable treatment for juvenile rheumatoid arthritis/juvenile idiopathic arthritis - a pilot study.

Authors:  Jeff Golini; Wendy Lou Jones
Journal:  J Med Food       Date:  2014-06-04       Impact factor: 2.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.